Global Translational Regenerative Medicine Market: Trends Analysis & Forecast to 2022 - Research and Markets

DUBLIN--()--The "Global Translational Regenerative Medicine Market: Trend Analysis and Forecast to 2022" report has been added to Research and Markets' offering.

Regenerative medicines deal with the process of engineering & replacing human cells, tissues or organs to restore or establish normal function. Regenerative medicines primarily help to restore structure and function of damaged tissues and organs by stimulating body's own repair mechanism. These medicines are used in wide range of degenerative disorders such as dermatology, neurodegenerative diseases, cardiovascular and orthopedic applications.

Rising awareness among people regarding regenerative medicines, increasing government initiative across the globe and growing aging population & healthcare expenditure are considered to be the key factors driving the growth of global translational regenerative medicine market. However, higher cost of research and development and complex government approval processes are major restraints for global regenerative medicine market. Increase in adoption of regenerative medicines and growth in aging population expected to bring new opportunities for growth over the forecast period.

North America is the largest market for regenerative medicines and accounted highest market shares as of 2015. High medical reimbursement facilities and technological advancement in the region are considered to be the key factors driving the dominance of North America in global regenerative medicines market.

Companies Mentioned

  • Anika Therapeutics
  • Anterogen
  • Athersys Inc.
  • Brainstorm Cell Therapeutics Inc.
  • Celgene Corporation
  • Gamida Cell Ltd.
  • MEDIPOST
  • Novartis
  • Nuvasive Inc.
  • Orthofix International N.V.
  • RTI Surgical Inc
  • Vericel Corporation

Key Topics Covered:

1. Report Overview

2. Executive Summary

3. Translational Regenerative Medicine Market Overview

4. Global Translational Regenerative Medicine Market, by Product Type, (USD Million) 2014-2022

5. Global Translational Regenerative Medicine Market, by Application, (USD Million) 2014-2022

6. Global Translational Regenerative Medicine Market, by Region, (USD Million) 2014-2022

7. Leading Companies

For more information about this report visit https://www.researchandmarkets.com/research/mrlkks/global

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Biopharmaceuticals

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Biopharmaceuticals